Unfortunately, we have no chance to examine immunosuppressive activity of tumor-infiltrating Tregs in mice treated with TNFR2-PLGA-ADR, due to the paucity of Tregs isolated from tumor tissues. The gene discussed is TNFRSF1B; the disease is neoplasm.